| Literature DB >> 29225308 |
Satoshi Nakamura1,2,3, Shoji Imamichi3,4, Kazuyoshi Masumoto5, Masashi Ito3,6, Akihisa Wakita1,3, Hiroyuki Okamoto1,3, Shie Nishioka1,3, Kotaro Iijima1, Kazuma Kobayashi1,3, Yoshihisa Abe3,6, Hiroshi Igaki1,3, Kazuyoshi Kurita2, Teiji Nishio7, Mitsuko Masutani3,4,8, Jun Itami1,3.
Abstract
This study aimed to evaluate the residual radioactivity in mice induced by neutron irradiation with an accelerator-based boron neutron capture therapy (BNCT) system using a solid Li target. The radionuclides and their activities were evaluated using a high-purity germanium (HP-Ge) detector. The saturated radioactivity of the irradiated mouse was estimated to assess the radiation protection needs for using the accelerator-based BNCT system. 24Na, 38Cl, 80mBr, 82Br, 56Mn, and 42K were identified, and their saturated radioactivities were (1.4 ± 0.1) × 102, (2.2 ± 0.1) × 101, (3.4 ± 0.4) × 102, 2.8 ± 0.1, 8.0 ± 0.1, and (3.8 ± 0.1) × 101 Bq/g/mA, respectively. The 24Na activation rate at a given neutron fluence was found to be consistent with the value reported from nuclear-reactor-based BNCT experiments. The induced activity of each nuclide can be estimated by entering the saturated activity of each nuclide, sample mass, irradiation time, and proton current into the derived activation equation in our accelerator-based BNCT system.Entities:
Keywords: accelerator-based BNCT; boron neutron capture therapy (BNCT); induced radioactivity; radioactivation
Mesh:
Substances:
Year: 2017 PMID: 29225308 PMCID: PMC5790759 DOI: 10.2183/pjab.93.051
Source DB: PubMed Journal: Proc Jpn Acad Ser B Phys Biol Sci ISSN: 0386-2208 Impact factor: 3.493